αB-crystallin extracellularly suppresses ADP-induced granule secretion from human platelets  by Enomoto, Yukiko et al.
FEBS Letters 583 (2009) 2464–2468journal homepage: www.FEBSLetters .orgaB-crystallin extracellularly suppresses ADP-induced granule secretion
from human platelets
Yukiko Enomoto a, Seiji Adachi b, Rie Matsushima-Nishiwaki b, Masayuki Niwa c,
Haruhiko Tokuda d, Shigeru Akamatsu e, Tomoaki Doi f, Hisaaki Kato f, Shinichi Yoshimura a,
Shinji Ogura f, Toru Iwama a, Osamu Kozawa b,*
aDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan
bDepartment of Pharmacology, Gifu University Graduate School of Medicine, Gifu 1-1 Yanagido, Japan
cMedical Science Division, United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan
dDepartment of Clinical Laboratory, National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan
eDepartment of Intensive Care Medicine, Matsunami General Hospital, Gifu, Japan
fDepartment of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu, Japana r t i c l e i n f o
Article history:
Received 19 May 2009
Accepted 19 June 2009
Available online 24 June 2009
Edited by Felix Wieland
Keywords:
Heat shock protein
aB-crystallin
Platelet
Adenosine diphosphate
Platelet-derived growth factor-AB
Serotonin0014-5793/$36.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.06.036
Abbreviations: HSP, heat shock protein; ADP, ad
mitogen-activated protein kinase; PDGF, platelet-d
serotonin; PRP, platelet rich plasma; ELISA, enzyme-l
SDS, sodium dodecyl sulfate; PAGE, SDS–polyacrylam
* Corresponding author. Fax: +81 58 230 6215.
E-mail address: okozawa@gifu-u.ac.jp (O. Kozawa)a b s t r a c t
aB-crystallin, a low-molecular-weight heat shock protein (HSP), has binding sites on platelets. How-
ever, the exact role of aB-crystallin is not clariﬁed. In this study, we investigated the effect of aB-
crystallin on platelet granule secretion. aB-crystallin attenuated the adenosine diphosphate
(ADP)-induced phosphorylation of p44/p42 mitogen-activated protein kinase (MAPK) and p38
MAPK. The ADP-stimulated HSP27 phosphorylation was markedly reduced by aB-crystallin. aB-crys-
tallin signiﬁcantly suppressed the ADP-induced secretions of both platelet-derived growth factor
(PDGF)-AB and serotonin. Therefore, our results strongly suggest that aB-crystallin extracellularly
suppresses platelet granule secretion by inhibition of HSP27 phosphorylation via p44/p42 MAPK
and p38 MAPK.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Heat shock proteins (HSPs), whose expression is induced by
various types of biological stress [1], protect cells from damage un-
der hazardous conditions, and their actions represent one of sev-
eral defense mechanisms that are operative in vivo. HSPs are
classiﬁed into high-molecular-weight HSPs and low-molecular-
weight HSPs according to their apparent molecular sizes [2].
High-molecular-weight HSPs such as HSP70 and HSP90 acts as
molecular chaperones in protein folding, oligomerization, and
translocation [3]. Though little has been known about the func-
tions of the low-molecular-weight HSPs such as aB-crystallin [4],
HSP27 [5] and HSP20 [6], it is generally accepted that they maychemical Societies. Published by E
enosine diphosphate; MAPK,
erived growth factor; 5-HT,
inked immunosorbent assay;
ide gel electrophoresis
.have chaperoning functions like the high-molecular-weight HSPs
[7,8]. The low-molecular-weight HSPs have a highly homologous
structure in their amino acid sequence, known as the aB-crystallin
domain [9].
It is recognized that HSP27 activity is regulated by post-transla-
tional modiﬁcations such as phosphorylation [7,10]. Human HSP27
becomes rapidly phosphorylated at these serine residues (Ser-15,
Ser-78 and Ser-82) in response to various stresses [11,12]. Adeno-
sine diphosphate (ADP), which activates platelets through P2-
receptors as one of the most potent agonists [13,14], was known
to induce HSP27 phosphorylation in human platelets [15]. Though
P2-receptors activation by ADP results in p38 mitogen-activated
protein kinase (MAPK) or p44/p42 MAPK activation in human
platelets [16,17], we have recently reported that ADP-induced
phosphorylation of HSP27 via p44/p42 MAPK and/or p38 MAPK
is correlated with ADP-induced platelet granule secretions of plate-
let-derived growth factor (PDGF)-AB and serotonin (5-HT) [18].
We have previously reported that the speciﬁc binding sites of
aB-crystallin exist on human platelets inhibits the aggregation in-
duced by thrombin or botrocetin but not adenosine diphosphatelsevier B.V. All rights reserved.
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platelet functions such as granule secretions remains unclear. In
the present study, we investigated the relationship between aB-
crystallin and the platelet granule secretion.
2. Materials and methods
2.1. Materials
ADP was purchased from Sigma–Aldrich Co. (St. Louis, MO). aB-
crystallin, a native protein puriﬁed from bovine eye lens, was pur-
chased from Assay Designs Inc. (Ann Arbor, MI). Other materials
and chemicals were obtained from commercial sources.
2.2. Preparation of platelets
Human blood was donated from healthy volunteers into 1/10
volume of a 3.8% sodium citrate and centrifuged for 12 min at
1000g to obtain platelet-rich-plasma (PRP). Platelet-poor plasma
was prepared from residual blood by centrifugation at 3000g for
5 min. All participants signed an informed consent agreement after
receiving a detailed explanation and the Committee of Ethics in
Gifu University Graduate School of Medicine approved this study.
2.3. Measurement of platelet aggregation induced by ADP
Platelet aggregation using citrated PRP was measured in an
aggregometer (PA 200 apparatus, Kowa Co. Ltd., Tokyo, Japan) at
37 C for 5 min with a stirring speed of 800 rpm after the addition
of 10 lM ADP. The percentage of transmittance of the isolated
platelets was recorded as 0%, and that of the appropriate plate-
let-poor plasma (blank) was recorded as 100%. When indicated,
the platelets were pretreated with the indicated doses of aB-crys-
tallin for 5 min. The distributions of aggregated particle size were
measured in laser scattering methods (small size, 9–25 lm, med-
ium size, 25–50 lm, large size, 50–75 lm).
2.4. Protein preparation after ADP stimulation
After the stimulation with 10 lM ADP for 10 min, platelet stim-
ulation was terminated by the addition of an ice-cold EDTA
(10 mM) solution. The mixture was centrifuged at 10 000g at
4 C for 2 min. The supernatant was isolated and stored at 20 C
for subsequent enzyme-linked immunosorbent assay (ELISA) to
measure the plasma levels of PDGF-AB and 5-HT. PDGF-AB Quanti-
kine and Serotonin ELISA purchased from R&D (Minneapolis, MN)
and IBL-Hamburg (Hamburg, Germany), respectively. For Western
blot analysis, the pellet was washed twice with phosphate-buf-
fered saline and then lysed and immediately boiled in a lysis buffer
containing 62.5 mM Tris/Cl, pH 6.8, 2% sodium dodecyl sulfate
(SDS), 50 mM dithiothreitol, and an 10% glycerol as previously de-
scribed [16].Fig. 1. Inﬂuence of aB-crystallin on the ADP-induced phosphorylation of MAPKs.
Platelets pretreated with various doses of aB-crystallin for 5 min were stimulated
with 10 lM ADP for 10 min. The extracts of cells were then subjected to SDS–PAGE
using antibodies against phospho-speciﬁc p44/p42 MAPK, or p44/p42 MAPK (A),
and phospho-speciﬁc p38 MAPK, p38 MAPK (B). The bar graph obtained from three
independent experiments quantiﬁed the phosphorylation levels of p38 MAPK are
shown. *P < 0.05, compared to the value of 10 lM ADP alone.2.5. Western blot analysis
A Western blot analysis was performed as described previously
[20]. SDS–polyacrylamide gel electrophoresis (PAGE) was per-
formed by the method of Laemmeli [21] in a 12% or 10% polyacryl-
amide gel. The antibodies used in these studies were anti-phospho
HSP27 (Ser-15), anti-phospho HSP27 (Ser-78) (Stressgen Biotech-
nologies, Victoria, BC, Canada), anti-phospho HSP27 (Ser-82) (Bio-
mol Research Laboratories, Plymouth Meeting, PA), anti-HSP27,
anti-phopho-p38 MAPK, anti-p38 MAPK, anti-phospho-p44/p42
MAPK, anti-p44/p42 MAPK antibody (Cell Signaling Inc., Beverly,
MA), respectively. Peroxidase-labeled anti-mouse IgG (Santa CruzBiotechnology Inc., CA, USA) or anti-rabbit IgG antibodies (KPL,
Gaithersburg, MD, USA) were used as secondary antibodies.
2.6. Densitometric analysis
The densitometric analysis was performed using scanner and
image analysis software (image J ver. 1.32). The phospho-p38
MAPK levels were calculated as follows: the back ground sub-
tracted signal intensity (total optical density) of each ADP-induced
phospho-p38 MAPK signal was normalized by total p38 MAPK sig-
nal and expressed as relative signal intensity to control.
2.7. Statistical analysis
The data were analyzed by Mann–Whitney’s U-test, and a
P < 0.05 was considered signiﬁcant. All data are presented as
means ± S.E.M.
3. Results
3.1. Inﬂuence of aB-crystallin on the ADP-induced phosphorylation of
p44/p42 MAPK, p38 MAPK and HSP27 in human platelets
We previously reported that ADP induces HSP27 phosphoryla-
tion via either p44/p42 MAPK activation or p38 MAPK activation
in human platelets [18]. Therefore, we next examined the effect
Fig. 2. Inﬂuence of aB-crystallin on the ADP-induced phosphorylation of HSP27.
Platelets pretreated with various doses of aB-crystallin for 5 min were stimulated
with 10 lM ADP for 10 min. The extracts of cells were then subjected to SDS–PAGE
using antibodies against Ser-15, Ser-78, Ser-82-phospho-speciﬁc HSP27, or total
HSP27.
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and HSP27. As shown in Fig. 1, aB-crystallin markedly suppressed
ADP-induced phosphorylation of both p44/p42 MAPK and p38
MAPK. In addition, aB-crystallin concurrently attenuated ADP-in-
duced phosphorylation of HSP27 (Ser-15, Ser-78, and Ser-82)
(Fig. 2). These results clearly suggest that aB-crystallin suppresses
ADP-induced phosphorylation of HSP27 via either p44/p42 MAPK
or p38 MAPK in human platelets.
3.2. Inﬂuence of aB-crystallin on the ADP-induced granule secretion
from human platelets
We conﬁrmed that ADP certainly caused platelet aggregation
(Fig. 3, panel 1). aB-crystallin had little effect on the ADP-induced
platelet aggregation or distribution of aggregated particle sizes,
even when the platelets were treated with the increasing dose
(up to 6 lg/ml) of aB-crystallin as previously described [19]
(Fig. 3, panels 2–4).
Platelets contain various kinds of proteins, including PDGF-AB
in a-granules and 5-HT in dense granules [22]. ADP has been rec-
ognized to provoke granule secretion as well as aggregation in hu-
man platelets [23]. To evaluate whether aB-crystallin regulates
granule secretion from human platelets, we next examined the ef-
fect of aB-crystallin on the ADP-induced PDGF-AB or 5-HT secre-Fig. 3. Inﬂuence of aB-crystallin on the ADP-induced platelet aggregation. The platelet a
with various doses of aB-crystallin for 5 min. Black line indicated the percentage of tran
free-plasma was recorded as 100%). The distributions of aggregated particle size were me
25–50 lm, red line: 50–70 lm).tion from healthy human platelets. We ﬁrst conﬁrmed that
10 lM ADP stimulated secretion of PDGF-AB (Fig. 4A, lane 2 com-
pared with lane 1). Interestingly, aB-crystallin signiﬁcantly re-
duced ADP-induced secretion of PDGF-AB in a dose-dependent
manner (Fig. 4A, lanes 4 and 5). Moreover, ADP-induced secretion
of 5-HT (Fig. 4B, lane 2 compared with lane 1) was also dose depen-
dently suppressed by aB-crystallin (Fig. 4B, lanes 3–5). These re-
sults strongly suggest that aB-crystallin inhibits granule
secretions induced by ADP from human platelets.
4. Discussion
In the present study, we focused on the role and the mechanism
of aB-crystallin in human platelet granule secretion. We showed
that aB-crystallin dose-dependently attenuated granule secretions
of PDGF-AB and 5-HT in parallel with the phosphorylation levels of
p44/p42 MAPK, p38 MAPK and HSP27 in ADP-stimulated platelets.
We have previously reported that ADP-induced phosphorylation of
HSP27 via p44/p42 MAPK and p38 MAPK is sufﬁcient for platelet
granule secretion [18]. Taking into account of the present ﬁndings
that aB-crystallin markedly reduced the phosphorylation of HSP27
induced by ADP, it is most likely that aB-crystallin suppresses
platelet granule secretion via HSP27 phosphorylation through
p44/p42 MAPK and p38 MAPK. On the contrary, the ADP-induced
platelet aggregation was not affected by aB-crystallin. Our ﬁndings
are consistent with the previous report showing that the inhibition
of either p44/p42 MAPK or p38 MAPK pathways has no effect on
ADP-induced platelet aggregation [24]. Thus, it is probable that
HSP27 phosphorylation is sufﬁcient not for aggregation but for
secretion in human platelets. It has been reported that proteins
puriﬁed from Escherichia coli such as recombinant human HSP70
are frequently contaminated with lipopolysaccharide that is
known to affect platelets [25]. With regard to aB-crystallin we
used, it is a native protein puriﬁed from bovine eye lens with the
purity of >90% as determined by SDS–PAGE and Western blot
analysis. Therefore, we could exclude the possibility that the effect
of aB-crystallin in this study is due to contaminated
lipopolysaccharide.
aB-crystallin exists in various tissues and cells, including heart,
brain, and skeletal muscle [26–28]. It has been reported that the
levels of aB-crystallin in trabecular meshwork cells are markedly
decreased after 1 h in response to mechanical stretch [29]. We pre-
viously reported that the levels of aB-crystallin in injured arteries
were markedly lower than those of non-injured arteries in vivo,
and that aB-crystallin levels in plasma of cardiomyopathic ham-ggregation induced by 10 lM ADP was measured in healthy human PRP pretreated
smittance of each samples (the isolated platelets was recorded as 0%, and platelet-
asured in laser scattering methods (blue line: particle size was 9–25 lm, green line:
Fig. 4. Inﬂuence of aB-crystallin on the ADP-induced granule secretion. Platelets
pretreated with various doses of aB-crystallin for 5 min were stimulated with
10 lM ADP for 10 min. The mixture was centrifuged at 10 000g at 4 C for 2 min
and the supernatants were then subjected to ELISA for PDGF-AB (A) and 5-HT (B).
Representative results from six independent experiments are shown. *P < 0.05,
**P < 0.01, compared to the value of 10 lM ADP alone (lane 2, respectively).
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crystallin in normal blood vessel walls immediately responds to
mechanical stress, such as endothelial injury, and is released from
injured arterial wall into circulation. Thus, it is possible that aB-
crystallin truly functions in the regulation of human platelet gran-
ule secretion in vivo.
It is well known that platelets are reactive to various stimuli
and release the materials stored in the three speciﬁc granules;
dense granules, a-granules and lysosomes [22]. In the present
study, we showed that the suppressive effects of aB-crystallin on
the levels of PDGF-AB and 5-HT were closely related to the de-
creased phosphorylation levels of p44/p42 MAPK, p38 MAPK and
following HSP27. These ﬁndings suggest that aB-crystallin has an
inhibitory effect on platelet granule secretion from both dense
granules and a-granules, a major platelet function besides aggre-
gation. However, we could not distinguish exogenous ADP from
endogenously released ADP and exclude the possibility that thelatter might ﬁnally affect platelet aggregation, because ADP stored
in the dense granules of platelet is released by the exogenous stim-
uli including ADP itself composing a positive feedback loop [22].
In conclusion, our results strongly suggest that aB-crystallin
suppresses ADP-stimulated platelet granule secretion via p44/
p42 MAPK and p38 MAPK. Our present study might be able to
establish a novel clinical target against arterial thrombotic
diseases.
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